1585 results
-
List item
News: COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets
PRAC, Last updated: 19/03/2021 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 25-29 January 2021
CHMP, Last updated: 01/02/2021 -
List item
News: EMA recommends COVID-19 Vaccine AstraZeneca for authorisation in the EU
Last updated: 29/01/2021 -
List item
News: Extra dose from vials of Comirnaty COVID-19 vaccine
Last updated: 20/01/2021 -
List item
News: EMA recommends COVID-19 Vaccine Moderna for authorisation in the EU
Last updated: 06/01/2021 -
List item
News: EMA recommends first COVID-19 vaccine for authorisation in the EU
CHMP, Last updated: 22/12/2020 -
List item
News: Call for independent scientific experts to join EMA's Pharmacovigilance Risk Assessment Committee (PRAC) - deadline extended
PRAC, Last updated: 20/11/2020 -
List item
News: EMA starts review of dexamethasone for treating adults with COVID-19 requiring respiratory support
CHMP, Last updated: 02/09/2020 -
List item
Press release: Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 21-23 January 2020
CVMP, Last updated: 06/02/2020 -
List item
Press release: First vaccine to protect against Ebola
CHMP, Last updated: 14/11/2019 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 17-20 September 2018
CHMP, Last updated: 21/09/2018 -
List item
Press release: Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 11-13 September 2018
CVMP, Last updated: 14/09/2018 -
List item
Press release: Update on review of valsartan medicines: risk from NDMA remains low, a related substance NDEA also being investigated
Last updated: 13/09/2018 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 3-6 September 2018
PRAC, Last updated: 07/09/2018 -
List item
Press release: Update on review of valsartan medicines due to detection of NDMA: EMA reviewing valsartan produced by another company Zhejiang Tianyu
Last updated: 10/08/2018 -
List item
Press release: Esmya: new measures to minimise risk of rare but serious liver injury
Last updated: 08/08/2018 -
List item
Press release: Update on review of recalled valsartan medicines: preliminary assessment of possible risk to patients
Last updated: 02/08/2018 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 23-26 July 2018
CHMP, Last updated: 27/07/2018 -
List item
Press release: New medicine for hereditary rare disease
CHMP, Last updated: 27/07/2018 -
List item
Press release: Two new paediatric-use marketing authorisations recommended by CHMP
CHMP, Last updated: 27/07/2018 -
List item
Press release: EMA restricts use of prostate cancer medicine Xofigo
CHMP, Last updated: 27/07/2018 -
List item
Press release: Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 17–19 July 2018
CVMP, Last updated: 20/07/2018 -
List item
Press release: Update on review of valsartan medicines following detection of impurity in active substance: assessing potential impact on patients is priority
Last updated: 17/07/2018 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 9-12 July 2018
PRAC, Last updated: 13/07/2018 -
List item
Press release: EMA reviewing medicines containing valsartan from Zhejiang Huahai following detection of an impurity: some valsartan medicines being recalled across the EU
Last updated: 05/07/2018